Published in Mol Cell Proteomics on May 12, 2011
miR-34 - a microRNA replacement therapy is headed to the clinic. Front Genet (2012) 2.89
MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer (2012) 2.78
Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling. PLoS Genet (2011) 2.00
MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer. PLoS One (2013) 1.82
Mir-34: a new weapon against cancer? Mol Ther Nucleic Acids (2014) 1.81
Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity. Clin Dev Immunol (2012) 1.75
The role of miRNAs in regulating gene expression networks. J Mol Biol (2013) 1.74
Functional interplay between RNA-binding protein HuR and microRNAs. Curr Protein Pept Sci (2012) 1.71
Development of microRNA therapeutics is coming of age. EMBO Mol Med (2014) 1.60
miR-34: from bench to bedside. Oncotarget (2014) 1.59
Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness. Oncotarget (2013) 1.43
MicroRNA-34a upregulation during seizure-induced neuronal death. Cell Death Dis (2012) 1.20
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme. Oncogene (2012) 1.08
Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation. Cell Cycle (2015) 1.05
Effects of the miR-143/-145 microRNA cluster on the colon cancer proteome and transcriptome. J Proteome Res (2012) 1.03
The oncogenic role of Yin Yang 1. Crit Rev Oncog (2011) 1.02
Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer. Oncotarget (2015) 1.01
Yin Yang 1 is a target of microRNA-34 family and contributes to gastric carcinogenesis. Oncotarget (2014) 1.01
Regulation of senescence by microRNA biogenesis factors. Ageing Res Rev (2012) 0.99
Promiscuous targeting of polytopic membrane proteins to SecYEG or YidC by the Escherichia coli signal recognition particle. Mol Biol Cell (2011) 0.95
Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway. J Radiat Res (2013) 0.95
MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer. Oncotarget (2016) 0.94
Chronic ethanol feeding alters miRNA expression dynamics during liver regeneration. Alcohol Clin Exp Res (2012) 0.93
In-depth analysis shows synergy between erlotinib and miR-34a. PLoS One (2014) 0.93
A combined approach of quantitative interaction proteomics and live-cell imaging reveals a regulatory role for endoplasmic reticulum (ER) reticulon homology proteins in peroxisome biogenesis. Mol Cell Proteomics (2013) 0.92
miR-34 and p53: New Insights into a Complex Functional Relationship. PLoS One (2015) 0.91
Mgr2 promotes coupling of the mitochondrial presequence translocase to partner complexes. J Cell Biol (2012) 0.91
The emerging functions of the p53-miRNA network in stem cell biology. Cell Cycle (2012) 0.90
MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer. Oncotarget (2015) 0.90
Identification of novel targets for miR-29a using miRNA proteomics. PLoS One (2012) 0.90
KITLG is a novel target of miR-34c that is associated with the inhibition of growth and invasion in colorectal cancer cells. J Cell Mol Med (2014) 0.88
Post-transcriptional homeostasis and regulation of MCM2-7 in mammalian cells. Nucleic Acids Res (2012) 0.86
p53-Regulated Networks of Protein, mRNA, miRNA, and lncRNA Expression Revealed by Integrated Pulsed Stable Isotope Labeling With Amino Acids in Cell Culture (pSILAC) and Next Generation Sequencing (NGS) Analyses. Mol Cell Proteomics (2015) 0.86
Quantitative proteomic analysis of gene regulation by miR-34a and miR-34c. PLoS One (2014) 0.85
Chemical tools for temporally and spatially resolved mass spectrometry-based proteomics. Ann Biomed Eng (2013) 0.85
MicroRNA Target Identification-Experimental Approaches. Biology (Basel) (2013) 0.85
Proteomics for understanding miRNA biology. Proteomics (2012) 0.85
Non-coding RNAs in lung cancer. Oncoscience (2014) 0.83
Post-transcriptional regulation of DNA damage-responsive gene expression. Antioxid Redox Signal (2013) 0.83
Early targets of miR-34a in neuroblastoma. Mol Cell Proteomics (2014) 0.82
LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a. Mol Cancer Res (2015) 0.82
Arachidonic acid downregulates acyl-CoA synthetase 4 expression by promoting its ubiquitination and proteasomal degradation. J Lipid Res (2014) 0.82
microRNA-34a as a Therapeutic Agent against Human Cancer. J Clin Med (2015) 0.81
A universally conserved ATPase regulates the oxidative stress response in Escherichia coli. J Biol Chem (2012) 0.81
Tiny giants of gene regulation: experimental strategies for microRNA functional studies. Wiley Interdiscip Rev Dev Biol (2016) 0.80
MicroRNA-205 targets tight junction-related proteins during urothelial cellular differentiation. Mol Cell Proteomics (2014) 0.79
P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy. Mol Cancer (2014) 0.78
Quantitative assessment of miR34a as an independent prognostic marker in breast cancer. Br J Cancer (2014) 0.78
Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects. World J Gastroenterol (2016) 0.77
Chronic DNA Replication Stress Reduces Replicative Lifespan of Cells by TRP53-Dependent, microRNA-Assisted MCM2-7 Downregulation. PLoS Genet (2016) 0.77
Structure, expression and functions of MTA genes. Gene (2016) 0.77
MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC). Oncotarget (2015) 0.76
MicroRNA-34a Negatively Regulates Efferocytosis by Tissue Macrophages in Part via SIRT1. J Immunol (2015) 0.76
Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells. RNA (2015) 0.76
Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma. Int J Oncol (2016) 0.76
Dosage and temporal thresholds in microRNA proteomics. Mol Cell Proteomics (2014) 0.76
miRNAs and resistance to EGFR-TKIs in EGFR-mutant non-small cell lung cancer: beyond 'traditional mechanisms' of resistance. Ecancermedicalscience (2015) 0.76
Identification of targets of tumor suppressor microRNA-34a using a reporter library system. Proc Natl Acad Sci U S A (2017) 0.75
Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies. Curr Oncol Rep (2017) 0.75
Post-transcriptional regulation of MTA family by microRNAs in the context of cancer. Cancer Metastasis Rev (2014) 0.75
MicroRNA-34a promotes genomic instability by a broad suppression of genome maintenance mechanisms downstream of the oncogene KSHV-vGPCR. Oncotarget (2016) 0.75
The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels. PLoS One (2015) 0.75
Digital analysis and epigenetic regulation of the signature of rejection in colorectal cancer. Oncoimmunology (2017) 0.75
Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer. Oncol Lett (2017) 0.75
PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a. J Exp Clin Cancer Res (2017) 0.75
MicroRNA regulation and analytical methods in cancer cell metabolism. Cell Mol Life Sci (2017) 0.75
Changes in CD73, CD39 and CD26 expression on T-lymphocytes of ANCA-associated vasculitis patients suggest impairment in adenosine generation and turn-over. Sci Rep (2017) 0.75
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Combinatorial microRNA target predictions. Nat Genet (2005) 50.48
On the origin of cancer cells. Science (1956) 49.55
Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis (1999) 45.01
MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell (2007) 38.42
The genomic landscapes of human breast and colorectal cancers. Science (2007) 38.12
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol (2008) 38.00
Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2008) 37.16
Surfing the p53 network. Nature (2000) 35.36
Human MicroRNA targets. PLoS Biol (2004) 34.51
Widespread changes in protein synthesis induced by microRNAs. Nature (2008) 31.44
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics (2002) 30.58
RAS is regulated by the let-7 microRNA family. Cell (2005) 30.24
A microRNA component of the p53 tumour suppressor network. Nature (2007) 19.25
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell (2007) 14.58
Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem (2010) 12.06
TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell (2006) 11.85
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature (2010) 10.09
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell (2006) 9.80
Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet (2011) 9.79
Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell (2007) 9.51
p53 regulates mitochondrial respiration. Science (2006) 9.06
A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A (2008) 7.14
Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle (2007) 7.00
p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol (2007) 6.87
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med (2011) 6.85
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol (2010) 6.67
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene (2007) 6.55
The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science (2010) 6.38
miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A (2008) 6.24
The miR-34 family in cancer and apoptosis. Cell Death Differ (2009) 5.92
Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature (2000) 4.93
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle (2008) 4.35
The interplay between MYC and HIF in cancer. Nat Rev Cancer (2008) 3.97
Desperately seeking microRNA targets. Nat Struct Mol Biol (2010) 3.85
Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res (2008) 3.81
A parsimonious model for gene regulation by miRNAs. Science (2011) 3.79
p53 enters the microRNA world. Cancer Cell (2007) 3.78
axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol (1991) 3.57
Yin Yang 1 is a negative regulator of p53. Cell (2004) 3.24
Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res (2010) 3.21
The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res (2007) 2.92
Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol Ther (2011) 2.75
Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res (2010) 2.19
Global analysis of cellular protein translation by pulsed SILAC. Proteomics (2009) 2.15
Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev (2010) 2.14
MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood (2009) 2.07
Role for histone deacetylase 1 in human tumor cell proliferation. Mol Cell Biol (2007) 2.07
Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. Proc Natl Acad Sci U S A (2006) 2.05
AXL is a potential target for therapeutic intervention in breast cancer progression. Cancer Res (2008) 2.01
Multiple roles for the receptor tyrosine kinase axl in tumor formation. Cancer Res (2005) 1.87
A novel putative tyrosine kinase receptor with oncogenic potential. Oncogene (1991) 1.81
The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Mol Cell Biol (2003) 1.77
Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics. Mol Cell Proteomics (2009) 1.75
Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer. Oncogene (2011) 1.75
Stringent doxycycline-dependent control of gene activities using an episomal one-vector system. Nucleic Acids Res (2005) 1.74
Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch (2011) 1.72
YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc Natl Acad Sci U S A (2004) 1.62
Role of miR-34c microRNA in the late steps of spermatogenesis. RNA (2010) 1.60
Eph-ephrin signalling in adult tissues and cancer. Curr Opin Cell Biol (2008) 1.52
The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation. Mol Cell Biol (2009) 1.42
Proteomics characterization of mouse kidney peroxisomes by tandem mass spectrometry and protein correlation profiling. Mol Cell Proteomics (2007) 1.41
Survivin as a global target of intrinsic tumor suppression networks. Cell Cycle (2009) 1.36
The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats. FEBS J (2011) 1.20
Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a. J Proteome Res (2010) 1.17
A gene regulation system with four distinct expression levels. J Gene Med (2006) 0.93
Inducible microRNA expression by an all-in-one episomal vector system. Nucleic Acids Res (2006) 0.87
Structural determinants outside the PXDLS sequence affect the interaction of adenovirus E1A, C-terminal interacting protein and Drosophila repressors with C-terminal binding protein. Biochim Biophys Acta (2001) 0.84
Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle (2007) 7.00
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle (2008) 4.35
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
MicroRNA-34a regulates cardiac ageing and function. Nature (2013) 4.03
Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc Natl Acad Sci U S A (2002) 3.55
miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle (2011) 3.15
Comparison of gene expression profiles between human and mouse monocyte subsets. Blood (2009) 3.15
High-resolution gene expression profiling for simultaneous kinetic parameter analysis of RNA synthesis and decay. RNA (2008) 3.13
Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science (2003) 3.00
Protein labeling by iTRAQ: a new tool for quantitative mass spectrometry in proteome research. Proteomics (2007) 2.97
Dual role of mitofilin in mitochondrial membrane organization and protein biogenesis. Dev Cell (2011) 2.52
Cytoscape: software for visualization and analysis of biological networks. Methods Mol Biol (2011) 2.43
Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res (2005) 2.37
Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res (2010) 2.19
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J Clin Invest (2014) 2.01
Mitochondrial preprotein translocase of trypanosomatids has a bacterial origin. Curr Biol (2011) 1.98
Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line. Oncogene (2005) 1.93
Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe (2010) 1.91
The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop. Proc Natl Acad Sci U S A (2011) 1.90
Autonomous role of medullary thymic epithelial cells in central CD4(+) T cell tolerance. Nat Immunol (2010) 1.89
Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J Infect Dis (2009) 1.87
Strain-specific genes of Helicobacter pylori: genome evolution driven by a novel type IV secretion system and genomic island transfer. Nucleic Acids Res (2010) 1.80
Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch (2011) 1.72
Role of MINOS in mitochondrial membrane architecture: cristae morphology and outer membrane interactions differentially depend on mitofilin domains. J Mol Biol (2012) 1.61
Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J Neurosci (2007) 1.58
Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. Mol Cell Proteomics (2005) 1.57
Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes. Infect Immun (2006) 1.57
Rcf1 mediates cytochrome oxidase assembly and respirasome formation, revealing heterogeneity of the enzyme complex. Cell Metab (2012) 1.48
Shy1 couples Cox1 translational regulation to cytochrome c oxidase assembly. EMBO J (2007) 1.47
Treatment algorithms for chronic osteomyelitis. Dtsch Arztebl Int (2012) 1.47
Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene (2005) 1.47
Psb27, a cyanobacterial lipoprotein, is involved in the repair cycle of photosystem II. Plant Cell (2006) 1.46
AP4 encodes a c-MYC-inducible repressor of p21. Proc Natl Acad Sci U S A (2008) 1.45
Negative regulation of the EGFR-MAPK cascade by actin-MAL-mediated Mig6/Errfi-1 induction. Mol Cell (2009) 1.44
Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness. Oncotarget (2013) 1.43
Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2. Blood (2010) 1.42
Proteomics characterization of mouse kidney peroxisomes by tandem mass spectrometry and protein correlation profiling. Mol Cell Proteomics (2007) 1.41
Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. Cell Cycle (2007) 1.39
Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proc Natl Acad Sci U S A (2011) 1.36
Molecular signatures of self-renewal, differentiation, and lineage choice in multipotential hemopoietic progenitor cells in vitro. Mol Cell Biol (2004) 1.35
Embryonic endothelial progenitor cells expressing a broad range of proangiogenic and remodeling factors enhance vascularization and tissue recovery in acute and chronic ischemia. FASEB J (2005) 1.33
Efficient isolation and gene expression profiling of small numbers of neural crest stem cells and developing Schwann cells. J Neurosci (2004) 1.33
Common and unique gene expression signatures of human macrophages in response to four strains of Mycobacterium avium that differ in their growth and persistence characteristics. Infect Immun (2005) 1.29
Tmem16b is specifically expressed in the cilia of olfactory sensory neurons. Chem Senses (2010) 1.26
c-MYC delays prometaphase by direct transactivation of MAD2 and BubR1: identification of mechanisms underlying c-MYC-induced DNA damage and chromosomal instability. Cell Cycle (2007) 1.25
Detection of novel biomarkers of liver cirrhosis by proteomic analysis. Hepatology (2009) 1.24
Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and β-catenin predicts distant metastasis of colon cancer. Clin Cancer Res (2012) 1.21
Coa3 and Cox14 are essential for negative feedback regulation of COX1 translation in mitochondria. J Cell Biol (2010) 1.20
Mdm38 interacts with ribosomes and is a component of the mitochondrial protein export machinery. J Cell Biol (2006) 1.19
AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer. J Exp Med (2013) 1.19
Temperature-sensitive eIF5A mutant accumulates transcripts targeted to the nonsense-mediated decay pathway. J Biol Chem (2006) 1.18
Composition and topology of the endoplasmic reticulum-mitochondria encounter structure. J Mol Biol (2011) 1.17
Dual function of Sdh3 in the respiratory chain and TIM22 protein translocase of the mitochondrial inner membrane. Mol Cell (2011) 1.14
Characterization of epithelial senescence by serial analysis of gene expression: identification of genes potentially involved in prostate cancer. Cancer Res (2002) 1.13
The crystal structure of the non-liganded 14-3-3sigma protein: insights into determinants of isoform specific ligand binding and dimerization. Cell Res (2005) 1.13
The proinflammatory cytokine-induced IRG1 protein associates with mitochondria. J Interferon Cytokine Res (2009) 1.13
Epigenetic silencing of 14-3-3sigma in cancer. Semin Cancer Biol (2006) 1.13
Members of the E2D (UbcH5) family mediate the ubiquitination of the conserved cysteine of Pex5p, the peroxisomal import receptor. J Biol Chem (2008) 1.13
The role of epigenetic inactivation of 14-3-3sigma in human cancer. Cell Res (2005) 1.11
Transcript profiling of CD16-positive monocytes reveals a unique molecular fingerprint. Eur J Immunol (2012) 1.11
Salinomycin induces autophagy in colon and breast cancer cells with concomitant generation of reactive oxygen species. PLoS One (2012) 1.11
Coupling of mitochondrial import and export translocases by receptor-mediated supercomplex formation. Cell (2013) 1.11
Cellular target genes of Epstein-Barr virus nuclear antigen 2. J Virol (2006) 1.10
Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study. Mol Cell Proteomics (2013) 1.09
SNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition. EMBO J (2013) 1.09
The c-MYC-AP4-p21 cascade. Cell Cycle (2009) 1.08
Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A. Nucleic Acids Res (2006) 1.08
Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression. Oncogene (2004) 1.08
Characterization of 14-3-3sigma dimerization determinants: requirement of homodimerization for inhibition of cell proliferation. Cell Cycle (2006) 1.07
Induction of cullin 7 by DNA damage attenuates p53 function. Proc Natl Acad Sci U S A (2007) 1.06
Top-down de Novo protein sequencing of a 13.6 kDa camelid single heavy chain antibody by matrix-assisted laser desorption ionization-time-of-flight/time-of-flight mass spectrometry. Anal Chem (2010) 1.05
MITRAC links mitochondrial protein translocation to respiratory-chain assembly and translational regulation. Cell (2012) 1.04
Analysis of 14-3-3sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma. Oncogene (2003) 1.04
Identification of proteomic differences between squamous cell carcinoma of the lung and bronchial epithelium. Mol Cell Proteomics (2009) 1.04
Mitochondrial outer membrane proteome of Trypanosoma brucei reveals novel factors required to maintain mitochondrial morphology. Mol Cell Proteomics (2012) 1.03
p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer. Cancer Res (2013) 1.03
DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene. Dis Colon Rectum (2007) 1.02
The bacterial SRP receptor, SecA and the ribosome use overlapping binding sites on the SecY translocon. Traffic (2011) 1.01
YidC occupies the lateral gate of the SecYEG translocon and is sequentially displaced by a nascent membrane protein. J Biol Chem (2013) 1.00
Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner. J Clin Invest (2002) 1.00
The p53/microRNA network in cancer: experimental and bioinformatics approaches. Adv Exp Med Biol (2013) 0.99
Ubp15p, a ubiquitin hydrolase associated with the peroxisomal export machinery. J Biol Chem (2011) 0.98
New dimensions in the study of protein complexes using quantitative mass spectrometry. FEBS Lett (2009) 0.98
PEX14 is required for microtubule-based peroxisome motility in human cells. J Cell Sci (2011) 0.98
MAL/MRTF-A controls migration of non-invasive cells by upregulation of cytoskeleton-associated proteins. J Cell Sci (2012) 0.98
Structure and function of intact photosystem 1 monomers from the cyanobacterium Thermosynechococcus elongatus. Biochemistry (2010) 0.97
Study of early leaf senescence in Arabidopsis thaliana by quantitative proteomics using reciprocal 14N/15N labeling and difference gel electrophoresis. Mol Cell Proteomics (2007) 0.96
Role of mitochondrial inner membrane organizing system in protein biogenesis of the mitochondrial outer membrane. Mol Biol Cell (2012) 0.96